Find clinical trials for Triple Negative Breast Cancer in Miami, FL

in patients with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received a...

This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...

This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effec...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC) or non-sma...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...